SGYP Synergy Pharmaceuticals Inc.

$1.89 +1.07%

5,048,932 Shares Traded
6,905,203 Average Volume (last 30 days)

as of February 23, 2018 EST IEX Real-Time Price

Short Pain Metrics

Approximate Amount of Money Shorts Have Lost on the Day: $1.53 million
If Intiated on the First, Shorts Have Realized a Year to Date Return of:24.08%
If Intiated One Month Ago, Shorts Have Realized a Return of:29.55%
If Initiated Five Days ago, Shorts Have Realized a Return of:11.85%
Peer Potential Short Squeezes Near Real Time Screener
*Please note the actual returns of shorts could be different as they started from different points

Daily Indicators

Daily Short Pain Indicator [i] - Always Use Fundamentals on EverythingNeutral
200 Day Moving Average Indicator Bearish
50 Day Moving Average Indicator Bearish
52 Week High/Low Indicator Neutral

Short Stats

Short Percent to Float 34.12%
Short Interest76.5 million
Float224.24 million
Short Ratio9.44
Market Cap$418.42 million
Market Maker ActivityDaily Short Volume

News

02-22-2018
INVESTOR ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Synergy Pharmaceuticals Inc. of a Class Action and a Lead Plaintiff Deadline of April 10, 2018 (Business Wire)
02-22-2018
INVESTOR ALERT: Brower Piven Encourages Shareholders Who Have Losses In Excess Of $100,000 From Investment In Synergy Pharmaceuticals Inc. To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit (Business Wire)
02-20-2018
The Klein Law Firm Reminds Investors of an Investigation Concerning Possible Violations of Federal Securities Laws by Synergy Pharmaceuticals Inc. (SGYP) (Business Wire)
02-20-2018
Kessler Topaz Meltzer & Check, LLP Announces Shareholder Class Action Lawsuit Filed against Synergy Pharmaceuticals Inc. (Business Wire)
02-20-2018
Tracking John Paulson's Paulson & Company Portfolio - Q4 2017 Update (SeekingAlpha)
02-18-2018
SYNERGY PHARMACEUTICALS INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing in Synergy Pharmaceuticals, Inc. to Contact the Firm (Business Wire)
02-17-2018
The Klein Law Firm Notifies Investors of an Investigation Concerning Possible Violations of Federal Securities Laws by Synergy Pharmaceuticals Inc. (Business Wire)
02-16-2018
Robbins Arroyo LLP: Synergy Pharmaceuticals Inc. (SGYP) Misled Shareholders According to a Recently Filed Class Action (Business Wire)
02-16-2018
Synergy Pharma (SGYP) Presents At Leerink Partners 7th Annual Global Healthcare Conference - Slideshow (SeekingAlpha)
02-16-2018
SGYP INVESTOR ALERT: The Law Offices of Vincent Wong Reminds Investors of an Investigation Involving Possible Securities Fraud Violations by the Board of Directors of Synergy Pharmaceuticals Inc. (Business Wire)


Smart Money Sentiment

Institutional Ownership (Top 15 Funds) 72.9%

Earnings Stats

PE Ratio -1.6
Dividend Yield 0%
Peer EarningsEarnings Calendar

Technicals

200 Day Moving Average $3.03
50 Day Moving Average $2.18
52 Week High $5.97
52 Week Low $1.68



Data provided for free by IEX. Questions? Read the FAQ